211 related articles for article (PubMed ID: 37259801)
21. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry.
O'Connor JB; Falk GW; Richter JE
Am J Gastroenterol; 1999 Aug; 94(8):2037-42. PubMed ID: 10445525
[TBL] [Abstract][Full Text] [Related]
22. Dysplasia in Random Biopsies from Barrett's Surveillance Is an Important Marker for More Severe Pathology.
Noordzij IC; Van Loon van de Ende MCM; Curvers WL; van Lijnschoten G; Huysentruyt CJ; Schoon EJ
Dig Dis Sci; 2021 Jun; 66(6):1957-1964. PubMed ID: 32661766
[TBL] [Abstract][Full Text] [Related]
23. Symptoms and endoscopic features at barrett's esophagus diagnosis: implications for neoplastic progression risk.
Coleman HG; Bhat SK; Murray LJ; McManus DT; O'Neill OM; Gavin AT; Johnston BT
Am J Gastroenterol; 2014 Apr; 109(4):527-34. PubMed ID: 24589668
[TBL] [Abstract][Full Text] [Related]
24. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
[TBL] [Abstract][Full Text] [Related]
25. Novel Screening Tests for Barrett's Esophagus.
Codipilly DC; Iyer PG
Curr Gastroenterol Rep; 2019 Jul; 21(9):42. PubMed ID: 31346777
[TBL] [Abstract][Full Text] [Related]
26. Predictors of dysplastic and neoplastic progression of Barrett’s esophagus.
Alnasser S; Agnihotram R; Martel M; Mayrand S; Franco E; Ferri L
Can J Surg; 2019 Apr; 62(2):93-99. PubMed ID: 30907564
[TBL] [Abstract][Full Text] [Related]
27. The diagnosis and management of Barrett's esophagus.
DeMeester SR; DeMeester TR
Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
[TBL] [Abstract][Full Text] [Related]
28. Barrett's esophagus, towards improved clinical practice.
Martínez-Domínguez SJ; Lanas Á; Domper-Arnal MJ
Med Clin (Barc); 2022 Jul; 159(2):92-100. PubMed ID: 35606193
[TBL] [Abstract][Full Text] [Related]
29. Screening for Barrett's esophagus.
Zakko L; Lutzke L; Wang KK
Minerva Med; 2017 Feb; 108(1):28-42. PubMed ID: 27792223
[TBL] [Abstract][Full Text] [Related]
30. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
[TBL] [Abstract][Full Text] [Related]
31. Management of low-grade dysplasia in Barrett's esophagus.
Wani S
Curr Opin Gastroenterol; 2012 Jul; 28(4):370-6. PubMed ID: 22508323
[TBL] [Abstract][Full Text] [Related]
32. [Barrett esophagus--a premalignant disorder requiring a program of endoscopic follow-up?].
Cuković-Cavka S
Med Arh; 2003; 57(1 Suppl 1):35-8. PubMed ID: 12827965
[TBL] [Abstract][Full Text] [Related]
33. Risk of neoplastic progression in Barrett's esophagus diagnosed as indefinite for dysplasia: a nationwide cohort study.
Kestens C; Leenders M; Offerhaus GJ; van Baal JW; Siersema PD
Endoscopy; 2015 May; 47(5):409-14. PubMed ID: 25521571
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis and recognition of early esophageal neoplasia.
Herszényi L; Pregun I; Tulassay Z
Dig Dis; 2009; 27(1):24-30. PubMed ID: 19439957
[TBL] [Abstract][Full Text] [Related]
35. [Barrett's esophagus: screening and prognosis].
Mazzucchelli L; Wagner AC
Ther Umsch; 2001 Mar; 58(3):158-64. PubMed ID: 11305154
[TBL] [Abstract][Full Text] [Related]
36. Advances in Biomarkers for Risk Stratification in Barrett's Esophagus.
Souza RF; Spechler SJ
Gastrointest Endosc Clin N Am; 2021 Jan; 31(1):105-115. PubMed ID: 33213790
[TBL] [Abstract][Full Text] [Related]
37. Esophageal adenocarcinoma in a first-degree relative increases risk for esophageal adenocarcinoma in patients with Barrett's esophagus.
Tofani CJ; Gandhi K; Spataro J; Yoo J; Murphy M; Mohan N; Daitch Z; Shah A; Janowski R; Huntley C; Dabbish N; Keith S; Coben R; Cohen S; Kastenberg D; Infantolino A
United European Gastroenterol J; 2019 Mar; 7(2):225-229. PubMed ID: 31080607
[TBL] [Abstract][Full Text] [Related]
38. How Should We Report Endoscopic Results in Patient's with Barrett's Esophagus?
Gorrepati VS; Sharma P
Dig Dis Sci; 2018 Aug; 63(8):2115-2121. PubMed ID: 29675664
[TBL] [Abstract][Full Text] [Related]
39. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
[TBL] [Abstract][Full Text] [Related]
40. New developments in the endoscopic surveillance of Barrett's oesophagus.
Bergman JJ; Tytgat GN
Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i38-42. PubMed ID: 15711007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
